HLA-C: An Accomplice in Rheumatic Diseases

Area of Science:

• Immunogenetics
• Rheumatology
• Autoimmunity

Background:

• Human Leukocyte Antigen C (HLA-C) is a class I MHC molecule involved in immune responses.
• While known for roles in cancer and viral protection, HLA-C is increasingly implicated in autoimmune and rheumatic diseases.
• Its contribution to autoimmunity was historically overshadowed by HLA-DRB1 associations.

Purpose of the Study:

• To review the accessory role of HLA-C in rheumatic diseases.
• To explore proposed mechanisms linking HLA-C to autoimmunity.
• To discuss the potential of HLA-C in predicting treatment response and guiding precision medicine.

Main Methods:

• Literature review of genetic association studies and mechanistic reports.
• Analysis of independent associations between HLA-C and rheumatic disease phenotypes.
• Examination of HLA-C's interactions with T cells and Natural Killer (NK) cells.

Main Results:

• Independent associations of HLA-C with rheumatic diseases and anticitrullinated peptide antibodies have been identified.
• HLA-C presents antigens to T cells and interacts with NK cell receptors.
• Polymorphisms in HLA-C and NK cell receptors may predict pharmacotherapy responsiveness.

Conclusions:

• HLA-C has an independent role in the pathogenesis of rheumatic diseases.
• Understanding HLA-C mechanisms in autoimmunity is crucial for identifying therapeutic targets.
• HLA-C research may inform precision pharmacologic treatments for rheumatic conditions.